Cargando…
Second primary colorectal cancer among endometrial cancer survivor: shared etiology and treatment sequelae
PURPOSE: To evaluate the incidence of colon cancer as a second primary cancer (CCSPC) and the survival outcomes of women with and without CCSPC after the diagnosis of endometrial cancer (EC). METHODS: The standardized incidence ratio (SIR) of CCSPC and survival outcomes of EC survivors with and with...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916981/ https://www.ncbi.nlm.nih.gov/pubmed/29445866 http://dx.doi.org/10.1007/s00432-018-2599-3 |
_version_ | 1783317105114873856 |
---|---|
author | Lim, Myong Cheol Won, Young-Joo Lim, Jiwon Seo, Sang-Soo Kang, Sokbom Yoo, Chong Woo Kim, Joo-Young Oh, Jae Hwan Bristow, Robert E. Park, Sang-Yoon |
author_facet | Lim, Myong Cheol Won, Young-Joo Lim, Jiwon Seo, Sang-Soo Kang, Sokbom Yoo, Chong Woo Kim, Joo-Young Oh, Jae Hwan Bristow, Robert E. Park, Sang-Yoon |
author_sort | Lim, Myong Cheol |
collection | PubMed |
description | PURPOSE: To evaluate the incidence of colon cancer as a second primary cancer (CCSPC) and the survival outcomes of women with and without CCSPC after the diagnosis of endometrial cancer (EC). METHODS: The standardized incidence ratio (SIR) of CCSPC and survival outcomes of EC survivors with and without CCSPC were analyzed using data from January 1 1993 to December 31 2011, obtained from the Korea Central Cancer Registry. RESULTS: Of 14,797 EC survivors, 147 (0.99%) developed CCSPC after an average interval of 5.5 years. The SIR of CCSPC among EC survivors was 2.56, higher than that of colon cancer in the general population. The SIR of CCSPC was highest for the ascending (3.77), followed by the transverse (3.45), descending colon (2.06), and rectum (1.99). The risk of a proximal site of CCSPC was high, especially within 5 years after the diagnosis of EC in the ascending (SIR, 4.37) and transverse (4.91) colon, and in young survivors (< 60 years) in the ascending (5.19) and transverse (3.82) colon. The 5- and 10-year overall survival rates were 84.8 and 80.4% among survivors with EC only and 89.2 and 76.3% for survivors with CCSPC, respectively. CONCLUSIONS: The risk of CCSPC among EC survivors increases especially in the proximal colon in young survivors. These results could be used for surveillance and counseling of EC survivors. |
format | Online Article Text |
id | pubmed-5916981 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-59169812018-04-30 Second primary colorectal cancer among endometrial cancer survivor: shared etiology and treatment sequelae Lim, Myong Cheol Won, Young-Joo Lim, Jiwon Seo, Sang-Soo Kang, Sokbom Yoo, Chong Woo Kim, Joo-Young Oh, Jae Hwan Bristow, Robert E. Park, Sang-Yoon J Cancer Res Clin Oncol Original Article – Cancer Research PURPOSE: To evaluate the incidence of colon cancer as a second primary cancer (CCSPC) and the survival outcomes of women with and without CCSPC after the diagnosis of endometrial cancer (EC). METHODS: The standardized incidence ratio (SIR) of CCSPC and survival outcomes of EC survivors with and without CCSPC were analyzed using data from January 1 1993 to December 31 2011, obtained from the Korea Central Cancer Registry. RESULTS: Of 14,797 EC survivors, 147 (0.99%) developed CCSPC after an average interval of 5.5 years. The SIR of CCSPC among EC survivors was 2.56, higher than that of colon cancer in the general population. The SIR of CCSPC was highest for the ascending (3.77), followed by the transverse (3.45), descending colon (2.06), and rectum (1.99). The risk of a proximal site of CCSPC was high, especially within 5 years after the diagnosis of EC in the ascending (SIR, 4.37) and transverse (4.91) colon, and in young survivors (< 60 years) in the ascending (5.19) and transverse (3.82) colon. The 5- and 10-year overall survival rates were 84.8 and 80.4% among survivors with EC only and 89.2 and 76.3% for survivors with CCSPC, respectively. CONCLUSIONS: The risk of CCSPC among EC survivors increases especially in the proximal colon in young survivors. These results could be used for surveillance and counseling of EC survivors. Springer Berlin Heidelberg 2018-02-14 2018 /pmc/articles/PMC5916981/ /pubmed/29445866 http://dx.doi.org/10.1007/s00432-018-2599-3 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article – Cancer Research Lim, Myong Cheol Won, Young-Joo Lim, Jiwon Seo, Sang-Soo Kang, Sokbom Yoo, Chong Woo Kim, Joo-Young Oh, Jae Hwan Bristow, Robert E. Park, Sang-Yoon Second primary colorectal cancer among endometrial cancer survivor: shared etiology and treatment sequelae |
title | Second primary colorectal cancer among endometrial cancer survivor: shared etiology and treatment sequelae |
title_full | Second primary colorectal cancer among endometrial cancer survivor: shared etiology and treatment sequelae |
title_fullStr | Second primary colorectal cancer among endometrial cancer survivor: shared etiology and treatment sequelae |
title_full_unstemmed | Second primary colorectal cancer among endometrial cancer survivor: shared etiology and treatment sequelae |
title_short | Second primary colorectal cancer among endometrial cancer survivor: shared etiology and treatment sequelae |
title_sort | second primary colorectal cancer among endometrial cancer survivor: shared etiology and treatment sequelae |
topic | Original Article – Cancer Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916981/ https://www.ncbi.nlm.nih.gov/pubmed/29445866 http://dx.doi.org/10.1007/s00432-018-2599-3 |
work_keys_str_mv | AT limmyongcheol secondprimarycolorectalcanceramongendometrialcancersurvivorsharedetiologyandtreatmentsequelae AT wonyoungjoo secondprimarycolorectalcanceramongendometrialcancersurvivorsharedetiologyandtreatmentsequelae AT limjiwon secondprimarycolorectalcanceramongendometrialcancersurvivorsharedetiologyandtreatmentsequelae AT seosangsoo secondprimarycolorectalcanceramongendometrialcancersurvivorsharedetiologyandtreatmentsequelae AT kangsokbom secondprimarycolorectalcanceramongendometrialcancersurvivorsharedetiologyandtreatmentsequelae AT yoochongwoo secondprimarycolorectalcanceramongendometrialcancersurvivorsharedetiologyandtreatmentsequelae AT kimjooyoung secondprimarycolorectalcanceramongendometrialcancersurvivorsharedetiologyandtreatmentsequelae AT ohjaehwan secondprimarycolorectalcanceramongendometrialcancersurvivorsharedetiologyandtreatmentsequelae AT bristowroberte secondprimarycolorectalcanceramongendometrialcancersurvivorsharedetiologyandtreatmentsequelae AT parksangyoon secondprimarycolorectalcanceramongendometrialcancersurvivorsharedetiologyandtreatmentsequelae |